Icon
+91 94997 68112
Login Register

Naprelan - (375 mg, 500 mg, 750 mg; Tablet Extended Release)

Naproxen Sodium Alvogen
375 mg, 500 mg, 750 mg; Tablet Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
NAPRELAN Tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. It is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea.
Yes
****** (*****) *** *** ***** ** **** **** ** *** ****** ******* ******** ** **** **, **** *** *** ************ ********* ** ****. ****** ** *** ******** ***** ****** **** ***-************ & **********. ***** ******** ***** ***** **** '* ****** ** ******* **** ****** ******** *** *******.
  1. ********* **, **** : ***** ******** **** ***** *** **** *** **** ** ****** *********** ****** ******* ******** ** **** **, ****.
  2. ******* **, **** : **** ***** * **** ******* ***** ** *** ******** ***** *** *** ******** ******** ** *******.
  3. *****, **** : *** ******** ***** ****** ** ***** **** **** '* ****** *** *******.
  4. *********, **** : ***** ********* ******* *** ***** ******** ** ******** ******, ******* ******* ** ********.
  5. *****, **** : *** ******** ***** ****** ** ***** ******* (*) **** '* ****** *** ************* ** *** ***** **** ***** ************ *** ******, *** (**) ***** '* ****** ****** *** ******** ***** *** * ****** ** *** ***-************ ********.
  6. . : **** ******* ******** *** ***** **** ********.
  7. *** *, **** : *** ******* ******* ***** ** ******* ******** *** ******** ***** '* ************* **** *** **** ****** *** *******, *** ******** *** **** **** ** *** ******** ***** *** * ************* ** ** ******* ***** '* ******* ********* *** **** ******.
  8. *******, **** : **** ***** * ********* ** *** *.*. ******** ***** *** *** ******** ******** ** ******* ******* ******* ******* ** * ****** ** ***** '* **** ** *** ******* ******* ** ********.
  9. ********, **** : ***** ***** *** ****** ** **** '* ******* **** ********* *** ***** * ************ *** *********** ****** *** **************** *** ** *********** ******* *** *** ***-************ *** ********** ** *** ********** ******. ***** **** *** ***** ******** ******** ****** ******* **** ********* **** ***** ****** **, ****.
  10. ****** **, **** : *** ******** ***** ***** **** ****** '*(***** '*) ******** ****** ******* ********* **** '* ****** **. *,***,***, *** **** *** ************ *** ******* *** **** *** ******** ****** **** *** ******* ** ********* *************.
  11. ****** **, **** : ******(*****) *********** ************ ***** ** *** ******** ****** *******.
  12. ***** *, **** : ****** & **** ******* * ********** ********* ** *** ***** ** ***** ****** **** *** $*** ** **** *** *** ****** *** ******* **** ****

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.